Fluid Balance During Closure of Atrial Septal Defect
Protein Distribution and Colloid Osmotic Pressure in Children With Volume and Pressure Loading Due to Congenital Heart Defects
1 other identifier
observational
41
1 country
1
Brief Summary
This project will evaluate fluid balance and oedema formation in children with the same congenital heart disease (Atrial Septal Defect) who will either go through heart surgery with the use of Cardio Pulmonary Bypass and hypothermia or through interventional catheterization. The investigators will measure interstitial colloid osmotic pressure, distribution of proteins and cytokines. The study hypothesis is that "Oedema developed during heart surgery is caused by reduced colloid osmotic pressure gradient through the capillary membrane".
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2012
CompletedFirst Posted
Study publicly available on registry
December 31, 2012
CompletedStudy Start
First participant enrolled
February 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2017
CompletedApril 11, 2017
April 1, 2017
3.9 years
December 21, 2012
April 8, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Interstitial colloid osmotic pressure
During surgery or interventional closure
Study Arms (2)
Interventional closure
Interventional catheterization closure
Open Heart Surgery
Surgery for Atrial septal defect
Eligibility Criteria
Children with Atrial Septal Defect scheduled for interventional closure with device or surgical repair
You may qualify if:
- The diagnosis of Atrial Septal Defect scheduled for closure
- Informed consent
You may not qualify if:
- Renal failure,
- liver failure,
- coexisting cardiac malformations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oslo University Hospitallead
- University of Bergencollaborator
Study Sites (1)
Oslo University Hospital
Oslo, Norway
Biospecimen
Interstitial fluid Serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marianne M Indrebo, MD
Oslo University Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD Research fellow
Study Record Dates
First Submitted
December 21, 2012
First Posted
December 31, 2012
Study Start
February 1, 2013
Primary Completion
January 1, 2017
Study Completion
January 1, 2017
Last Updated
April 11, 2017
Record last verified: 2017-04